{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:07:16Z","timestamp":1792076836469,"version":"4.4.0"},"reference-count":97,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>RNA-dependent RNA polymerase (RdRP) is essential for the replication and expression of RNA viral genomes. This class of viruses comprise a large number of highly pathogenic agents that infect essentially all species of plants and animals including humans. Infections often lead to epidemics and pandemics that have remained largely out of control due to the lack of specific and reliable preventive and therapeutic regimens. This unmet medical need has led to the exploration of new antiviral targets, of which RdRP is a major one, due to the fact of its obligatory need in virus growth. Recent studies have demonstrated the ability of several synthetic nucleoside analogs to serve as mimics of the corresponding natural nucleosides. These mimics cause stalling\/termination of RdRP, or misincorporation, preventing virus replication or promoting large-scale lethal mutations. Several such analogs have received clinical approval and are being routinely used in therapy. In parallel, the molecular structural basis of their inhibitory interactions with RdRP is being elucidated, revealing both traditional and novel mechanisms including a delayed chain termination effect. This review offers a molecular commentary on these mechanisms along with their clinical implications based on analyses of recent results, which should facilitate the rational design of structure-based antiviral drugs.<\/jats:p>","DOI":"10.3390\/ijms232012649","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T04:40:36Z","timestamp":1666586436000},"page":"12649","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Inhibition of Viral RNA-Dependent RNA Polymerases by Nucleoside Inhibitors: An Illustration of the Unity and Diversity of Mechanisms"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1329-1786","authenticated-orcid":false,"given":"Sailen","family":"Barik","sequence":"first","affiliation":[{"name":"EonBio, 3780 Pelham Drive, Mobile, AL 36619, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1007\/s00705-016-2880-1","article-title":"Taxonomy of the order Mononegavirales: Update 2016","volume":"161","author":"Afonso","year":"2016","journal-title":"Arch. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/0092-8674(87)90515-0","article-title":"An antitermination protein engages the elongating transcription apparatus at a promoter-proximal recognition site","volume":"50","author":"Barik","year":"1987","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Panya, A., Songprakhon, P., Panwong, S., Jantakee, K., Kaewkod, T., Tragoolpua, Y., Sawasdee, N., Lee, V.S., Nimmanpipug, P., and Yenchitsomanus, P.T. (2021). Cordycepin inhibits virus replication in dengue virus-infected Vero cells. Molecules, 26.","DOI":"10.3390\/molecules26113118"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1021\/acsomega.1c05998","article-title":"Potent inhibitory activities of the adenosine analogue Cordycepin on SARS-CoV-2 replication","volume":"7","author":"Rabie","year":"2022","journal-title":"ACS Omega"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e00674","DOI":"10.1002\/prp2.674","article-title":"Nucleotide analogues as inhibitors of SARS-CoV polymerase","volume":"8","author":"Ju","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"113201","DOI":"10.1016\/j.ejmech.2021.113201","article-title":"RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic","volume":"213","author":"Tian","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e01652-20","DOI":"10.1128\/AAC.01652-20","article-title":"Repurposing nucleoside analogs for human coronaviruses","volume":"65","author":"Zandi","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Tchesnokov, E.P., Feng, J.Y., Porter, D.P., and G\u00f6tte, M. (2019). Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by Remdesivir. Viruses, 11.","DOI":"10.3390\/v11040326"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.RA120.013679","article-title":"Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1074\/jbc.AC120.013056","article-title":"The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1548.e4","DOI":"10.1016\/j.molcel.2021.01.035","article-title":"Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication","volume":"81","author":"Bravo","year":"2021","journal-title":"Mol. Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.abj5508","article-title":"4\u2032-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication","volume":"375","author":"Sourimant","year":"2022","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"855496","DOI":"10.3389\/fimmu.2022.855496","article-title":"Molnupiravir and its antiviral activity against COVID-19","volume":"13","author":"Tian","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1038\/s41467-020-18463-z","article-title":"Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis","volume":"11","author":"Shannon","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","article-title":"Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis","volume":"28","author":"Kabinger","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"100867","DOI":"10.1016\/j.jbc.2021.100867","article-title":"Decoding molnupiravir-induced mutagenesis in SARS-CoV-2","volume":"297","year":"2021","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.abn0048","article-title":"Lethal mutagenesis as an antiviral strategy","volume":"375","author":"Swanstrom","year":"2022","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"43395","DOI":"10.1038\/srep43395","article-title":"GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses","volume":"7","author":"Lo","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Guedj, J., Piorkowski, G., Jacquot, F., Madelain, V., Nguyen, T.H.T., Rodallec, A., Gunther, S., Carbonnelle, C., Mentr\u00e9, F., and Raoul, H. (2018). Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques. PLoS Med., 15.","DOI":"10.1371\/journal.pmed.1002535"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/infdis\/jiaa290","article-title":"Remdesivir (GS-5734) Is Efficacious in Cynomolgus macaques infected with Marburg virus","volume":"222","author":"Porter","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2017.12.021","article-title":"Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus","volume":"151","author":"Bixler","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"104899","DOI":"10.1016\/j.antiviral.2020.104899","article-title":"Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses","volume":"182","author":"Konkolova","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Boccuto, A., Dragoni, F., Picarazzi, F., Lai, A., Ventura, C.D., Veo, C., Giammarino, F., Saladini, F., Zehender, G., and Zazzi, M. (2021). Sofosbuvir selects for drug-resistant amino acid variants in the Zika virus RNA-dependent RNA-polymerase complex in vitro. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052670"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"105331","DOI":"10.1016\/j.antiviral.2022.105331","article-title":"Remdesivir efficacy against yellow fever in a hamster model","volume":"203","author":"Julander","year":"2022","journal-title":"Antivir. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"104708","DOI":"10.1016\/j.antiviral.2020.104708","article-title":"Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro","volume":"175","author":"Dragoni","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","volume":"117","author":"Feldmann","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"109882","DOI":"10.1016\/j.celrep.2021.109882","article-title":"Remdesivir overcomes the S861 roadblock in SARS-CoV-2 polymerase elongation complex","volume":"37","author":"Wu","year":"2021","journal-title":"Cell Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e00162-20","DOI":"10.1128\/CMR.00162-20","article-title":"Remdesivir against COVID-19 and other viral diseases","volume":"34","author":"Malin","year":"2020","journal-title":"Clin Microbiol. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/jcc.24662","article-title":"Molecular simulations to delineate functional conformational transitions in the HCV polymerase","volume":"38","author":"Sesmero","year":"2017","journal-title":"J. Comput. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Venkataraman, S., Prasad, B.V.L.S., and Selvarajan, R. (2018). RNA-dependent RNA polymerases: Insights from structure, function and evolution. Viruses, 10.","DOI":"10.3390\/v10020076"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Selisko, B., Papageorgiou, N., Ferron, F., and Canard, B. (2018). Structural and functional basis of the fidelity of nucleotide selection by flavivirus RNA-dependent RNA polymerases. Viruses, 10.","DOI":"10.3390\/v10020059"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.3390\/v7072808","article-title":"Using the hepatitis C virus RNA-dependent RNA polymerase as a model to understand viral polymerase structure, function and dynamics","volume":"7","author":"Sesmero","year":"2015","journal-title":"Viruses"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Wu, J., Ye, H.-Q., Zhang, Q.-Y., Lu, G., Zhang, B., and Gong, P. (2020). A conformation-based intra-molecular initiation factor identified in the flavivirus RNA-dependent RNA polymerase. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008484"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"W276","DOI":"10.1093\/nar\/gkac240","article-title":"Search and sequence analysis tools services from EMBL-EBI in 2022","volume":"50","author":"Madeira","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"114800","DOI":"10.1016\/j.bcp.2021.114800","article-title":"Remdesivir: Quo vadis?","volume":"193","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"914.e10","DOI":"10.1016\/j.cell.2020.04.011","article-title":"The architecture of SARS-CoV-2 transcriptome","volume":"181","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.abf3546","article-title":"Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome","volume":"372","author":"Bhatt","year":"2021","journal-title":"Science"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2135.e5","DOI":"10.1016\/j.molcel.2021.02.036","article-title":"The SARS-CoV-2 subgenome landscape and its novel regulatory features","volume":"81","author":"Wang","year":"2021","journal-title":"Mol. Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/2211-5463.13413","article-title":"Viral and cellular translation during SARS-CoV-2 infection","volume":"12","author":"Eriani","year":"2022","journal-title":"FEBS Open Bio."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9372","DOI":"10.1073\/pnas.1201130109","article-title":"RNA 3\u2032-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10\/nsp14 exoribonuclease complex","volume":"109","author":"Bouvet","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1038\/s41467-019-10280-3","article-title":"Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors","volume":"10","author":"Kirchdoerfer","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-020-2368-8","article-title":"Structure of replicating SARS-CoV-2 polymerase","volume":"584","author":"Hillen","year":"2020","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1073\/pnas.0508200103","article-title":"Discovery of an RNA virus 3\u2032\u21925\u2032 exoribonuclease that is critically involved in coronavirus RNA synthesis","volume":"103","author":"Minskaia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"E3900","DOI":"10.1073\/pnas.1323705111","article-title":"One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities","volume":"111","author":"Subissi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"E162","DOI":"10.1073\/pnas.1718806115","article-title":"Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA","volume":"115","author":"Ferron","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"417.e413","DOI":"10.1016\/j.cell.2020.05.034","article-title":"Structural basis for RNA replication by the SARS-CoV-2 polymerase","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"107774","DOI":"10.1016\/j.celrep.2020.107774","article-title":"Structural and biochemical characterization of the nsp12-nsp7-nsp8 core polymerase complex from SARS-CoV-2","volume":"31","author":"Peng","year":"2020","journal-title":"Cell Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1021\/acscentsci.0c01242","article-title":"Modeling the binding mechanism of Remdesivir, Favilavir, and Ribavirin to SARS-CoV-2 RNA-dependent RNA polymerase","volume":"7","author":"Bylehn","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"16156","DOI":"10.1074\/jbc.AC120.015720","article-title":"Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action","volume":"295","author":"Tchesnokov","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1038\/s41467-020-16234-4","article-title":"Stringent control of the RNA-dependent RNA polymerase translocation revealed by multiple intermediate structures","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"101518","DOI":"10.1016\/j.jbc.2021.101518","article-title":"Activation of the SARS-CoV-2 NSP14 3\u2032-5\u2032 exoribonuclease by NSP10 and response to antiviral inhibitors","volume":"298","author":"Riccio","year":"2022","journal-title":"J. Biol. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"16577","DOI":"10.1038\/s41598-020-73641-9","article-title":"Sofosbuvir-terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir","volume":"10","author":"Jockusch","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s42003-022-03101-9","article-title":"Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture","volume":"5","author":"Wang","year":"2022","journal-title":"Commun. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1006\/viro.1995.0013","article-title":"Phosphorylation of Ser232 directly regulates the transcriptional activity of the P protein of human respiratory syncytial virus: Phosphorylation of Ser237 may play an accessory role","volume":"213","author":"Barik","year":"1995","journal-title":"Virology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.virusres.2017.01.008","article-title":"Polymerases of paramyxoviruses and pneumoviruses","volume":"234","author":"Fearns","year":"2017","journal-title":"Virus Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e0120621","DOI":"10.1128\/JVI.01206-21","article-title":"Respiratory syncytial virus phosphoprotein residue S156 plays a role in regulating genome transcription and replication","volume":"95","author":"Beavis","year":"2021","journal-title":"J. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"40920","DOI":"10.1038\/srep40920","article-title":"The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication","volume":"7","author":"Sacramento","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1038\/s41598-017-06612-2","article-title":"Evaluation of Sofosbuvir (\u03b2-D-2\u2032-deoxy-2\u2032-\u03b1-fluoro-2\u2032-\u03b2-C-methyluridine) as an inhibitor of Dengue virus replication","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"De Freitas, C.S., Higa, L.M., Sacramento, C.Q., Ferreira, A.C., Reis, P.A., Delvecchio, R., Monteiro, F.L., Barbosa-Lima, G., Westgarth, H.J., and Vieira, Y.R. (2019). Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007072"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"29812","DOI":"10.1074\/jbc.M705274200","article-title":"Characterization of the metabolic activation of hepatitis C virus nucleoside inhibitor beta-D-2\u2032-Deoxy-2\u2032-fluoro-2\u2032-C-methylcytidine (PSI-6130) and identification of a novel active 5\u2032-triphosphate species","volume":"282","author":"Ma","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1128\/AAC.02666-14","article-title":"Efficiency of incorporation and chain termination determines the inhibition potency of 2\u2032-modified nucleotide analogs against hepatitis C virus polymerase","volume":"58","author":"Fung","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/095632020601700203","article-title":"Inhibition of hepatitis C replicon RNA synthesis by \u03b2-d-2\u2032-deoxy-2\u2032-fluoro-2\u2032-C-methylcytidine: A specific inhibitor of hepatitis C virus replication","volume":"17","author":"Stuyver","year":"2006","journal-title":"Antivir. Chem. Chemother."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1128\/AAC.01184-07","article-title":"The mechanism of action of \u03b2-d-2\u2032-deoxy-2\u2032-fluoro-2\u2032-C-methylcytidine involves a second metabolic pathway leading to \u03b2-d-2\u2032-deoxy-2\u2032-fluoro-2\u2032-C-methyluridine 5\u2032-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymerase","volume":"52","author":"Murakami","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_66","first-page":"727","article-title":"Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors","volume":"72","author":"Xu","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3851\/IMP3149","article-title":"In vitro selection of resistance to sofosbuvir in HCV replicons of genotype-1 to -6","volume":"22","author":"Xu","year":"2017","journal-title":"Antivir. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Shoun, A.A., Abozahra, R., Baraka, K., Mehrez, M., and Abdelhamid, S.M. (2022). Identifying different mutation sites leading to resistance to the direct-acting antiviral (DAA) Sofosbuvir in hepatitis C virus patients from Egypt. Microorganisms, 10.","DOI":"10.3390\/microorganisms10040679"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Younas, S., Sumrin, A., Hussain, N., and Bilal, M. (2022). Identification of NS5B resistance against SOFOSBUVIR in hepatitis C virus genotype 3a, naive and treated patients. J. Appl. Microbiol., Online ahead of print.","DOI":"10.1111\/jam.15754"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.1128\/JVI.00386-12","article-title":"Structure of hepatitis C virus polymerase in complex with primer-template RNA","volume":"86","author":"Mosley","year":"2012","journal-title":"J. Virol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1128\/AAC.00433-06","article-title":"General catalytic deficiency of hepatitis C virus RNA polymerase with an S282T mutation and mutually exclusive resistance towards 2\u2032-modified nucleotide analogues","volume":"50","author":"Dutartre","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13321-020-00440-9","article-title":"EDock: Blind protein-ligand docking by replica-exchange Monte Carlo simulation","volume":"12","author":"Zhang","year":"2020","journal-title":"J. Cheminfor."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1126\/science.1259210","article-title":"Viral replication. Structural basis for RNA replication by the hepatitis C virus polymerase","volume":"347","author":"Appleby","year":"2015","journal-title":"Science"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"115783","DOI":"10.1016\/j.taap.2021.115783","article-title":"Remdesivir: Molecular and functional measures of mitochondrial safety","volume":"433","author":"Bjork","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e02237-20","DOI":"10.1128\/AAC.02237-20","article-title":"Off-target in vitro profiling demonstrates that remdesivir is a highly selective antiviral agent","volume":"65","author":"Xu","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e00492-17","DOI":"10.1128\/AAC.00492-17","article-title":"Nucleotide substrate specificity of anti-Hepatitis C virus nucleoside analogs for human mitochondrial RNA polymerase","volume":"61","author":"Ehteshami","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1261\/rna.2860603","article-title":"RNAi: Mammalian oocytes do it without RNA-dependent RNA polymerase","volume":"9","author":"Stein","year":"2003","journal-title":"RNA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cub.2012.04.011","article-title":"The Caenorhabditis elegans RDE-10\/RDE-11 complex regulates RNAi by promoting secondary siRNA amplification","volume":"22","author":"Zhang","year":"2012","journal-title":"Curr. Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"112517","DOI":"10.1016\/j.biopha.2021.112517","article-title":"RdRp inhibitors and COVID-19: Is molnupiravir a good option?","volume":"146","author":"Hashemian","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e01508-20","DOI":"10.1128\/AAC.01508-20","article-title":"Development of a simple in vitro assay to identify and evaluate nucleotide analogs against SARS-CoV-2 RNA-dependent RNA polymerase","volume":"65","author":"Lu","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00214-020-02656-2","article-title":"Favipiravir tautomerism: A theoretical insight","volume":"139","author":"Antonov","year":"2020","journal-title":"Theor. Chem. Acc."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0166-3542(92)90026-2","article-title":"Aryl phosphate derivatives of AZT retain activity against HIV1 in cell lines which are resistant to the action of AZT","volume":"17","author":"McGuigan","year":"1992","journal-title":"Antivir. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1021\/acs.jmedchem.7b00734","article-title":"The ProTide prodrug technology: From the concept to the clinic","volume":"61","author":"Mehellou","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2040206618775243","DOI":"10.1177\/2040206618775243","article-title":"Phosphoramidates and phosphonamidates (ProTides) with antiviral activity","volume":"26","author":"Slusarczyk","year":"2018","journal-title":"Antivir. Chem. Chemother."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1021\/acs.chemrestox.7b00030","article-title":"Why prodrugs and propesticides succeed","volume":"30","author":"Casida","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"12044","DOI":"10.1021\/acs.jmedchem.2c00758","article-title":"Optimization of the prodrug moiety of Remdesivir to improve lung exposure\/selectivity and enhance anti-SARS-CoV-2 activity","volume":"65","author":"Hu","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1021\/jm100863x","article-title":"Discovery of a \u03b2-D-2-deoxy-2-\u03b1-fluoro-2-\u03b2-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus","volume":"53","author":"Sofia","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jps.2600790604","article-title":"Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells","volume":"79","author":"Artursson","year":"1990","journal-title":"J. Pharm. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.virol.2011.12.021","article-title":"Matrigel embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle","volume":"425","author":"Benedicto","year":"2012","journal-title":"Virology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1099\/vir.0.055772-0","article-title":"Direct visualization of hepatitis C virus-infected Huh7.5 cells with a high titre of infectious chimeric JFH1-EGFP reporter virus in three-dimensional Matrigel cell cultures","volume":"95","author":"Liu","year":"2014","journal-title":"J. Gen. Virol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00253-014-6253-y","article-title":"Hydrogels for 3D mammalian cell culture: A starting guide for laboratory practice","volume":"99","author":"Ruedinger","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Dank\u00f3, T., Pet\u0151v\u00e1ri, G., Raffay, R., Sztankovics, D., Moldvai, D., Vetl\u00e9nyi, E., Krencz, I., R\u00f3kusz, A., Sipos, K., and Visnovitz, T. (2022). Characterisation of 3D bioprinted human breast cancer model for in vitro drug and metabolic targeting. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137444"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1465-9921-10-102","article-title":"Influenza H5N1 virus infection of polarized human alveolar epithelial cells and lung microvascular endothelial cells","volume":"10","author":"Chan","year":"2009","journal-title":"Respir. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.tim.2013.02.004","article-title":"Respiratory syncytial virus interaction with human airway epithelium","volume":"21","author":"Villenave","year":"2013","journal-title":"Trends Microbiol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Bitko, V., Garmon, N.E., Cao, T., Estrada, B., Oakes, J.E., Lausch, R.N., and Barik, S. (2004). Activation of cytokines and NF-kappa B in corneal epithelial cells infected by respiratory syncytial virus: Potential relevance in ocular inflammation and respiratory infection. BMC Microbiol., 4.","DOI":"10.1186\/1471-2180-4-28"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrm859","article-title":"Opinion: Building epithelial architecture: Insights from three-dimensional culture models","volume":"3","author":"Zegers","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/1040841X.2012.711740","article-title":"Animal models in virus research: Their utility and limitations","volume":"39","author":"Louz","year":"2013","journal-title":"Crit. Rev. Microbiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/20\/12649\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:58:39Z","timestamp":1760144319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/20\/12649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":97,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["ijms232012649"],"URL":"https:\/\/doi.org\/10.3390\/ijms232012649","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]}}}